Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pain (P), fatigue (F), and
insomnia
(I) are among the most prevalent, distressing, and undermanaged symptoms experienced by cancer patients. Research has demonstrated that
PFI
co-occur; what remain unclear are the patterns and stability of
PFI
and the patient, disease, and treatment characteristics that predict
PFI
patterns over time. This secondary analysis used a data set composed of 867 elders (46% women) who were newly diagnosed with breast, colorectal, lung, or prostate cancer and followed at 4 points during the year after diagnosis. The university's institutional review board approved this study. Descriptive statistics and multistate transition models using multinomial logistic regression were used. The typical participant was 72.6 years old, who reported 7.9 symptoms and 2.7 comorbidities. Previous
PFI
pattern was consistently associated with significantly increased risks of subsequent
PFI
pattern. At observations 1 to 3, lung cancer, treatment, higher comorbidity with breast cancer, and late-stage colorectal cancer were significantly associated with increased risks of
PFI
patterns. Advancing age was not significantly associated with increased risks of
PFI
patterns. Pain, fatigue, and
insomnia
co-occurrence declined over time but was associated with significantly increased risks of death or loss to follow-up and increased reports of other symptoms. Pain, fatigue, and
insomnia
co-occurrence is associated with adverse outcomes and should be proactively targeted for intervention.
...
PMID:Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. 1877 57